Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

MDS-PAS Genetic Nomenclature, Rare Diseases and Ataxia in Movement Disorders: A 3-Part Series

CME Credits:6Date:Jun 11, 2022 - Aug 20, 2022

Experienced / Intermediate

Program Description

The MDS-PAS Genetic Nomenclature, Rare Diseases and Ataxia in Movement Disorders: A 3-Part Series will be presented by MDS-PAS experts and will feature Genetics of Movement Disorders: Nomenclature and genotype-phenotype correlations, Rare Movement Disorders/Treatable disorders and Ataxias. Participants will have access to pre-recorded lectures and invited to attend a live virtual interactive question and answer (Q&A) session with the experts the following week.  

Participants are encouraged to attend all sessions but sessions are not interdependent...


  • Basic/Translational Neuroscience
  • Epidemiology & Environment
  • Etiology & Pathophysiology
  • Genetics
  • Hyperkinetic Movement Disorders
  • Other Movement Disorders
  • Therapies-Other
  • Therapies-Pharmacological


Course Directors

Orlando Barsottini, MD, PhD - Federal University of São Paulo, São Paulo, Brazil

Connie Marras, MD, PhD - Toronto Western Hospital, Toronto, ON, Canada

Nicolás Phielipp, MD - University of California Irvine, Irvine, CA, USA


Paula Saffie Awad, MD - CETRAM, Santiago, Chile

Sarah Camargos, MD - Federal University of Minas Gerais, Belo Horizonte, Brazil

Darius Ebrahimi-Fakhari, MD, PhD - Boston Children’s Hospital, Harvard University, Boston, MA, USA

Emilia Gatto, MD, FAAN - Sanatorio de la Trinidad Mitre, Buenos Aires, Argentina

Hyder (Buz) Jinnah, MD, PhD - Emory University School of Medicine, Atlanta, GA, USA

Jose Luiz Pedroso, MD, PhD - Federal University of São Paulo, São Paulo, Brazil

Liana Rosenthal, MD, PhD - Johns Hopkins School of Medicine, Baltimore, MD, USA

Course Purpose

The primary purpose of this course is to provide education in the area of genetic nomenclature, rare diseases and ataxia as it relates to movement disorders. This course is comprised of 3 independent sessions:  

Part 1: Genetics of Movement Disorders: Nomenclature and genotype-phenotype correlations

In the last decade, knowledge of the genetic determinants of movement disorders has seen dramatic progress, with many new genetic associations uncovered each year.  In response to this and pre-existing challenges in classification of causative genes and genetic risk factors, the nomenclature has evolved.  This session will explain the latest nomenclature system with an overview across each main phenotype, and provide a more in-depth examination of genotype-phenotype correlations in dystonia and pediatric movement disorders.  

Part 2: Rare Movement Disorders/Treatable disorders

New developments in understanding the pathophysiology of rare diseases, that manifest among other symptoms with movements 

disorders, have led to offer treatment for many of these conditions. This session will review these disorders and their treatments, following a brief 1- clinical vignette, 2- pathophysiology, 3- treatment format.  

Part 3: Ataxias 

Although most patients presenting with ataxias may have a sporadic disorder, there has been continuous progress in deciphering the molecular pathogenesis of degenerative ataxias. This session will discuss the newest forms of genetic ataxias, presenting practical ways of recognizing them, and also management of rare forms of ataxias.

Registration Fees:

Member: $15 USD

Non-Member: $50 USD

No-Fee Member: $5 USD

Registration is for the entire series. Participants can register throughout the series and access past sessions on-demand. Registration closes August 8, 2022. 


*Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of session.


To view additional details please click 'PROCEED TO COURSE'

Interactive Sessions

This online course consists of 3 independent sessions with live virtual Q&A sessions with the experts.


Part 1: Genetics of Movement Disorders: Nomenclature and genotype-phenotype correlations

Saturday, June 11, 2022 from 11:00-12:00 US Central Time


Part 2: Rare Movement Disorders/Treatable disorders

Saturday, July 9, 2022 from 11:00-12:00 US Central Time


Part 3: Ataxias 

Saturday, August 20, 2022 from 11:00-12:00 US Central Time


To convert to your local time zone, please click here:

Learning Objectives

Upon completion of this activity learners will be able to:

Part 1: Genetics of Movement Disorders: Nomenclature and genotype-phenotype correlations

1.  Demonstrate the principles of and rationale for the latest system of nomenclature of genetically determined movement disorders

2.  Know where to find the latest lists of causative genes and as yet unconfirmed associations

3.  Organize genotype-phenotype associations in dystonia and demonstrate the approach to genetic testing in dystonic disorders

4.  Distinguish genetic heterogeneity and phenotypic pleiotropy in pediatric movement disorders and plan an approach to genetic testing in children with movement disorders

Part 2: Rare Movement Disorders/Treatable disorders

1.  Identify treatable inherited rare disorders phenomenology/phenotype

2.  Define basic pathophysiology of treatable inherited rare disorders

3.  Evaluate which treatments may be available for these disorders


Part 3: Ataxias

1.  Summarize the diagnostic approach to patient with congenital, recessive and dominant ataxias

2.  Recognize clinical clues and plan diagnostic workup and management of patients with rare ataxia syndromes

Intended Audience

This activity is intended for movement disorder specialists, general neurologists with interest in movement disorders, movement disorder fellows/clinical fellows/clinical research fellows/residents in neurology, genetic counselors and physical therapists with interest in ataxia.

Accreditation Credit

Accreditation Statement 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The International Parkinson and Movement Disorder Society designates this activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.

Method of Participation

Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.

Staff Disclosure

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Hardware and Software Requirements

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.

2. Compatible with Windows PC and MAC (256 MB of RAM or higher).

3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.

4. Adobe Flash Player 12.0 (or higher). 

5. Adobe Reader to print certificate.  

Contact Us

MDS Education

MDS Secretariat Liaison

Nilda Toro

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice